BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20224552)

  • 1. Regulation of natural killer T-cell development by deubiquitinase CYLD.
    Lee AJ; Zhou X; Chang M; Hunzeker J; Bonneau RH; Zhou D; Sun SC
    EMBO J; 2010 May; 29(9):1600-12. PubMed ID: 20224552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer T cell-a cat o' nine lives!
    Joyce S; Gordy LE
    EMBO J; 2010 May; 29(9):1475-6. PubMed ID: 20442728
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of Con A-induced hepatitis induction in ICOS-deficient mice.
    Watanabe S; Ohnuki K; Hara Y; Ishida Y; Ikarashi Y; Ogawa S; Kishimoto H; Tanabe K; Abe R
    Immunol Lett; 2010 Jan; 128(1):51-8. PubMed ID: 19914290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rel/NF-kappaB family member RelA regulates NK1.1- to NK1.1+ transition as well as IL-15-induced expansion of NKT cells.
    Vallabhapurapu S; Powolny-Budnicka I; Riemann M; Schmid RM; Paxian S; Pfeffer K; Körner H; Weih F
    Eur J Immunol; 2008 Dec; 38(12):3508-19. PubMed ID: 19003818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor CYLD controls the function of murine regulatory T cells.
    Reissig S; Hövelmeyer N; Weigmann B; Nikolaev A; Kalt B; Wunderlich TF; Hahn M; Neurath MF; Waisman A
    J Immunol; 2012 Nov; 189(10):4770-6. PubMed ID: 23066153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective dendritic cell responses against listeriosis induced by the short form of the deubiquitinating enzyme CYLD are inhibited by full-length CYLD.
    Wurm R; Just S; Wang X; Wex K; Schmid U; Blanchard N; Waisman A; Schild HJ; Deckert M; Naumann M; Schlüter D; Nishanth G
    Eur J Immunol; 2015 May; 45(5):1366-76. PubMed ID: 25675948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
    Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
    Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
    J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.
    Noma H; Eshima K; Satoh M; Iwabuchi K
    Immunology; 2015 Sep; 146(1):89-99. PubMed ID: 25988531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling.
    Lee AJ; Wu X; Cheng H; Zhou X; Cheng X; Sun SC
    J Biol Chem; 2010 May; 285(21):15696-703. PubMed ID: 20233721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential requirement of IKK2 for CYLD-dependent representation of thymic and peripheral T-cell populations.
    Tsagaratou A; Grammenoudi S; Mosialos G
    Eur J Immunol; 2011 Oct; 41(10):3054-62. PubMed ID: 21728169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-181a/b-1 Is Not Required for Innate γδ NKT Effector Cell Development.
    Sandrock I; Ziętara N; Łyszkiewicz M; Oberdörfer L; Witzlau K; Krueger A; Prinz I
    PLoS One; 2015; 10(12):e0145010. PubMed ID: 26673421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICOS-dependent stimulation of NKT cells by marginal zone B cells.
    Zietara N; Łyszkiewicz M; Krueger A; Weiss S
    Eur J Immunol; 2011 Nov; 41(11):3125-34. PubMed ID: 21809338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7h is required for T cell activation, differentiation, and effector function.
    Nurieva RI; Mai XM; Forbush K; Bevan MJ; Dong C
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14163-8. PubMed ID: 14615582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes.
    Kadri N; Korpos E; Gupta S; Briet C; Löfbom L; Yagita H; Lehuen A; Boitard C; Holmberg D; Sorokin L; Cardell SL
    J Immunol; 2012 Apr; 188(7):3138-49. PubMed ID: 22371394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYLD is a crucial negative regulator of innate immune response in Escherichia coli pneumonia.
    Lim JH; Ha UH; Woo CH; Xu H; Li JD
    Cell Microbiol; 2008 Nov; 10(11):2247-56. PubMed ID: 18643924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hepatocyte-derived IL-7 in maintenance of intrahepatic NKT cells and T cells and development of B cells in fetal liver.
    Liang B; Hara T; Wagatsuma K; Zhang J; Maki K; Miyachi H; Kitano S; Yabe-Nishimura C; Tani-Ichi S; Ikuta K
    J Immunol; 2012 Nov; 189(9):4444-50. PubMed ID: 23018454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway.
    Tesio M; Tang Y; Müdder K; Saini M; von Paleske L; Macintyre E; Pasparakis M; Waisman A; Trumpp A
    J Exp Med; 2015 Apr; 212(4):525-38. PubMed ID: 25824820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF2 regulates peripheral CD8(+) T-cell and NKT-cell homeostasis by modulating sensitivity to IL-15.
    Villanueva JE; Malle EK; Gardam S; Silveira PA; Zammit NW; Walters SN; Brink R; Grey ST
    Eur J Immunol; 2015 Jun; 45(6):1820-31. PubMed ID: 25931426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.